4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-24-000011
Chief Executive Officer returned 11,173 shares (to the company)
- Chief Executive Officer acquired 198,517 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Virnich Daniel · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-21 | Returned to the company : show line 1 in the form | −11,173 | $0.60 | $6,673 | 718,430 | D |
| 2024-05-21 | Grant or award : show line 2 in the form | +198,517 | 916,947 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-21 | Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) | +496,293 | 496,293 | D |
Loading xslF345X05/edgardoc.xml…